Search

everythinglearnresearchcommunity

for

Search:↓

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

Ultraviolet light helped hair growth more effectively than triamcinolone acetonide.

Selumetinib significantly reduced tumor size and improved vision in a child with neurofibromatosis type 1.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

The Oat mouse model shows mild retinal degeneration, useful for testing treatments.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Injecting triamcinolone into the eyebrow area may help eyelash regrowth in alopecia areata patients.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Tailored treatments for aging brows and foreheads improve results.

The 755-nm alexandrite laser effectively and quickly treats trichostasis spinulosa with minimal pain and no side effects.

New treatment effectively reverses hair thinning in most patients with mild side effects.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Low-level light therapy safely improves hair growth and thickness for androgenetic alopecia.

Eyelash loss can temporarily occur from chemotherapy for retinoblastoma.

Sinapic acid and glabridin together help hair growth in androgenetic alopecia.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Spironolactone helps reduce fluid in the eye in Central Serous Chorioretinopathy, but doesn't improve vision and recurrence is common.

Bimatoprost may help with hair loss.

New treatments for male pattern hair loss look promising, but established treatments are still the main option.

PRP injections for hair growth can cause temporary vision loss, which may be resolved with treatment.

Surgical treatments and topical tofacitinib may help with vitiligo-related eyebrow and eyelash whitening, but more research is needed.

Steroid use can cause a rare eye condition called central serous retinopathy, which can lead to permanent vision damage.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Combination therapies work better than single treatments for hair loss.

The combination therapy was effective and well-tolerated, especially in young patients.